Myelodysplastic Syndrome - Pipeline Review, H2 2012 - New Market Research Report
Global Markets Direct's, 'Myelodysplastic Syndrome - Pipeline Review, H2 2012', provides an overview of the Myelodysplastic Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Myelodysplastic Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Myelodysplastic Syndrome. 'Myelodysplastic Syndrome - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor...
View full press release